Surgery – Body inserted urinary or colonic incontinent device or...
Reexamination Certificate
1999-10-04
2001-05-22
O'Connor, Cary (Department: 3736)
Surgery
Body inserted urinary or colonic incontinent device or...
Reexamination Certificate
active
06234955
ABSTRACT:
This invention pertains to the treatment of blood vessels and, more particularly, to the treatment of dilated veins.
Blood vessels, and specifically veins, in the gastrointestinal tract of a body can often become enlarged. For example, a vein which becomes enlarged and lengthened is known as a varix. Such varices can occur in the wall of the gastrointestinal tract, for example in the vicinity of the lower esophageal sphincter. A dilated vein at the margin of the anus or nearby within the rectum is known as a hemorrhoid. An erosion in the mucous membrane of the gastrointestinal tract is known as an ulcer. Bleeding from ulcers can be either from veins or arteries. Varices, hemorrhoids and ulcers are more suspectable to undesirable bleeding than normal vessels.
Sclerotherapy is used to treat bleeding of esophageal varices. However, rebleeding is still common in patients receiving sclerotherapy. In addition, the injection of sclerosing agents induces various local and systemic complications. Ligation was developed in an attempt to provide an endoscopic therapy that would be at least as effective as sclerotherapy but have fewer complications. Unfortunately, relatively large vessels can be difficult to ligate. In addition, the ligation procedure can cause tears in the vessel. Hemorrhoids have been treated in the same manner as varices, but these treatment techniques suffer from the same disadvantages discussed above.
For patients with severely bleeding ulcers, surgery may be required to cauterize the vasculature in the vicinity of the ulcer. Unfortunately, surgical intervention is a major operation with all attendant morbidities, mortality and risk of failure requiring further surgery.
As can be seen from the foregoing, there is a need for a new and improved method for treating varices, hemorrhoids and gastric ulcers.
In general, it is an object of the present invention to provide a minimally invasive method for injecting a material into a vessel in the gastrointestinal system of the body to substantially occlude the vessel.
Another object of the invention is to provide a method of the above character in which the injected material is a nonbiodegradable material.
Another object of the invention is to provide a method of the above character in which the material is injected as at least one solution and thereafter forms a solid.
Another object of the invention is to provide a method of the above character in which the at least one solution includes a solution from which a nonbiodegradable solid precipitates.
Another object of the invention is to provide a method of the above character in which the solution includes a biocompatible polymer and a biocompatible solvent.
REFERENCES:
patent: 3094122 (1963-06-01), Gauthier et al.
patent: 3204634 (1965-09-01), Koehn
patent: 4271827 (1981-06-01), Angelchik
patent: 4351333 (1982-09-01), Lazarus et al.
patent: 4424208 (1984-01-01), Wallace et al.
patent: 4582640 (1986-04-01), Smestad et al.
patent: 4773393 (1988-09-01), Haber et al.
patent: 4803075 (1989-02-01), Wallace et al.
patent: 4837285 (1989-06-01), Berg et al.
patent: 5007940 (1991-04-01), Berg
patent: 5067965 (1991-11-01), Ersek et al.
patent: 5116387 (1992-05-01), Berg
patent: 5158573 (1992-10-01), Berg
patent: 5204382 (1993-04-01), Wallace et al.
patent: 5258028 (1993-11-01), Ersek et al.
patent: 5301682 (1994-04-01), Debbas
patent: 5314473 (1994-05-01), Godin
patent: 5336263 (1994-08-01), Ersek et al.
patent: 5451406 (1995-09-01), Lawin et al.
patent: 5480644 (1996-01-01), Freed
patent: 5490984 (1996-02-01), Freed
patent: 5580568 (1996-12-01), Greff et al.
patent: 5667767 (1997-09-01), Greff et al.
patent: 5695480 (1997-12-01), Evans et al.
patent: 5702361 (1997-12-01), Evans et al.
patent: 5755658 (1998-05-01), Wallace et al.
patent: 5785642 (1998-07-01), Wallace et al.
patent: 5792478 (1998-08-01), Lawin et al.
patent: 5830178 (1998-11-01), Jones et al.
patent: 5861036 (1999-01-01), Godin
patent: 34223/95 (1996-05-01), None
patent: WO 97/19643 (1997-06-01), None
patent: WO 97/45131 (1997-12-01), None
patent: WO 98/01088 (1998-01-01), None
patent: WO 98/17200 (1998-04-01), None
patent: WO 98/17201 (1998-04-01), None
Donahue, P. et al., “Endoscopic Sclerosis Of The Gastric Cardia For Prevention Of Experimental Gastoresophageal Reflux” (1990)Gastrointestinal Endoscopy, pp. 253-258.
Society of Am. Gastrointestinal Endoscopic Surgeons, Los Angeles, CA, “Granting of Privileges for Laparascopic General Surgery”, (Mar. 1991),Am. Jrnl. of Surgery, vol. 161, pp. 324-325.
Aye, R.W. et al., “Early Results With the Laparoscopic Hill Repair”, (May 1994),Am. Jrnl. of Surgery, vol. 167, pp. 542-546.
Collard, J.M. et al., “Laparoscopic Antireflux Surgery/What is Real Progress?”, (1994),Annals of Surgery, vol. 220, No. 2, pp. 146-154.
DeMeester, T.R. et al., “Nissen Fundoplication for Gastroesophageal Reflux Disease”, (1986),Annals of Surgery, vol. 204, No. 1, pp. 9-20.
Donahue, P.E. et al., “The Floppy Nissen Fundoplication/ Effective Long-term Control of Pathologic Reflux”, (Jun. 1985),Arch Surg, vol. 120, pp. 663-668.
Ellis, Jr., F.H., “The Nissen Fundoplication”, (1992),Ann. Thorac. Surg., vol. 54, pp. 1231-1234.
Grande, L. et al., “Value of Nissen fundoplication in patients with gastro-oesophageal reflux judged by long-term sympton control”, (1994),Brit. Jnl. of Surgery, vol. 81, pp. 548-550.
Hill, L.D. et al., “Laparoscopic Hill Repair”, (Jan. 1994),Contemporary Surgery, vol. 44, No. 1, pp. 13-20.
Hunter, J.G. et al., “A Physiologic Approach to Laparoscopic Fundoplication for Gastroesophageal Reflux Disease”, (1996),Annals of Surgery, vol. 223, No. 6, pp. 673-687.
Ireland, A.C. et al., “Mechanisms underlying the antireflux action of fundoplication”, (1993),Gut, vol. 34, pp. 303-308.
Johansson, J. et al., “Outcome 5 years after 360° fundoplication for gastro-oesophageal reflux disease”, (Jan. 1993),Brit. Jnl. of Surgery, vol. 80, pp. 46-49.
Kauer, W.K.H. et al., “Mixed Reflux of Gastric and Duodenal Juices Is More Harmful to the Esophagus than Gastric Juice Alone/The Need for Surgical Therapy Re-Emphasized”, (1995)Annals of Surgery, vol. 222, No. 4, pp. 525-533.
Klingman, R.R. et al., “The Current Management of Gastroesophageal Reflux”, (1991),Adv. Surg., vol. 24, pp. 259-291.
Little, A.G., “Mechanisms of Action of Antireflux Surgery: Theory and Fact”, (1992),World Jnl. of Surgery, vol. 16, pp. 320-325.
Luostarinen, M., “Nissen Fundoplication for Reflux Esophagitis/Long-Term Clinical and Endoscopic Results in 109 of 127 Consecutive Patients”, (1993),Annals of Surgery, vol. 217, No. 4, pp. 329-337.
Luostarinen, M. et al., “Fate of Nissen fundoplication after 20 yerars. A clinical, endoscopical, and functional analysis”, (1993),Gut, vol. 34, pp. 1015-1020.
Malizia, A. et al., “Migration and Granulomatous Reaction After Periurethral injection of Polytef (Teflon)”, (Jun. 1984), JAMA, vol. 251, No. 24, pp. 3277-3281.
Martin, C. et al., “Collis-Nissen Gastroplasty Fundoplication For Complicated Gastro-Oesophageal Reflux Disease”, (1992),Aust. N.S. Jnl. Surg., vol. 62, pp. 126-129.
O'Connor, K.W. et al., “Endoscopic placement of collagen at the lower esophageal sphincter to inhibit gastroesophageal reflux: a pilot study of 10 medically intractable patients”, (1988),Gastrointestinal Endoscopy, vol. 34, No. 2, pp. 106-112.
O'Connor, K. W. et al., “An experimental endoscopic technique for reversing gastroesophageal reflux in dogs by injecting inert material in the distal esophagus”, (1984) Gatrointestinal Endoscopy, vol. 30, No. 5, pp. 275-280.
Ortiz, A. et al., “Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study”, (1996),Brit. Jnl. of Surg., vol. 83, 274-278.
Politano, V. et al., “Periurethral Teflon Injection for Urinary Incontinence”, (Feb. 1974)Jnl. Urology, vol. 111, pp. 180-183.
Pope, C., “The Quality of Life Following Antireflux Furgery”, (1992),Worl Jnl. of Surgery, vol. 16, pp. 355-358.
Schulman, C.C. et al., “Endoscopic injections of Teflon to treat urinary incontinence in women”, (Jan. 21, 1984) BMJ, vol.
Silverman David E.
Stein Alan
Enteric Medical Technologies, Inc.
Flehr Hohbach Test Albritton & Herbert LLP
O'Connor Cary
Szmal Brina
LandOfFree
Method for vascular occulusive therapy in gastrointestinal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for vascular occulusive therapy in gastrointestinal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for vascular occulusive therapy in gastrointestinal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2458298